Article Information
History
- November 1, 2021.
Article Versions
- Version 1 (October 30, 2021 - 06:43).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ebiowei S.F. Orubu1,4,*,
- Mohammed A. Samad2,
- Md. Tanvir Rahman3,
- Muhammad H. Zaman4 and
- Veronika J. Wirtz5
- 1Boston University Institute for Health System Innovation & Policy, Boston, USA
- 2Antimicrobial Resistance Action Centre, Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka-1341, Bangladesh; samad_blri{at}yahoo.co.nz
- 3Bangladesh Agricultural University, Department of Microbiology and Hygiene, Faculty of Veterinary Science, Mymensingh-2202, Bangladesh; tanvirahman{at}bau.edu.bd
- 4Boston University College of Engineering, Department of Biomedical Engineering, Boston, USA; zaman{at}bu.edu
- 5Boston University School of Public Health, Department of Global Health, Boston, USA; vwirtz{at}bu.edu
- ↵*Corresponding author: Email: sforubu{at}bu.edu
Posted November 01, 2021.
The integrity of the antimicrobial supply chain in Bangladesh: assessing the regulatory environment and contextual challenges
